Genome is a fintech startup dedicated to powering comprehensive financial services for companies, offering a wide array of features including a dedicated IBAN, multi-currency account, SEPA instant transfers, SWIFT transfers, and Visa debit cards. Founded in 2018 and headquartered in Lithuania, Genome enables seamless conduct of SEPA Instant, credit, and international transactions worldwide. The platform also provides multi-currency access, allowing effortless spending or conversion through web, app, or cards. Upon obtaining an international bank account number (IBAN), businesses can manage global finances and operations effortlessly. Genome's solution consolidates diverse financial tasks into an intuitive interface, further complemented by advanced payment safety tools protecting virtual and physical Visa Business cards accessible globally. The company caters to industries such as financial services, fintech, payments, and banking. Although no specific details of their last investment are available, Genome's offerings position it as a promising player in the financial technology space. For leading multi-currency corporate finance solutions, businesses can explore genome.eu.
There is no investment information
No recent news or press coverage available for Genome.